Moth tops most-recalled drug TV ads

Share this article:
Two ads for Lunesta's Sepracor ranked as the most-recalled new prescription drug spots of 2006, followed by two spots for Novartis' Zelnorm, according to a survey by IAG Research.

In the most-recalled spot, created by McCann-Erickson HumanCare, the ubiquitous luna moth lands in a man's room as a voice-over intones: “Are you at home trying to sleep, but your mind is still at the office?” In the second most-recalled spot, the moth flies through nocturnal vistas before landing on a woman's shoulder while questions flash on the screen: “Why's my mind so restless? Can anything help?”

Two executions from the Zelnorm “Tummies” series, by Deutsch, placed as the third- and fourth-most recalled ads. Ads featuring the Nasonex Bee, by BBDO New York, placed fifth and tenth. Rounding out the top ten were spots for GSK's Boniva; Merck/Schering-Plough's Vytorin; Merck's Fosamax; and GSK's Valtrex.

Fariba Zamaniyan, VP at IAG's pharmaceutical practice, said: “The above average performances achieved by these brands confirm that direct-to-consumer advertising for prescription drugs can achieve breakthrough and brand recognition, even within the rigid guidelines this category faces.

Share this article:

Email Newsletters

More in News

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?

In sunny world of LASIK marketers, a dark underbelly

In sunny world of LASIK marketers, a dark ...

Last week, the former FDA branch chief who originally approved LASIK machines asked FDA to reconsider its denial last month of his petition to ban these devices.

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.